Breast Cancer Research and Treatment

, Volume 39, Issue 2, pp 239–240 | Cite as

Endoglin/CD 105 may not be an optimal tumor endothelial treatment target

  • Arjan W. Griffioen
  • Cora A. Damen
  • Geert H. Blijham
  • Gerard Groenewegen
Letter to the editor

Keywords

Public Health Treatment Target Optimal Tumor 

References

  1. 1.
    Thorpe PE, Burrows FJ: Antibody-directed targeting of the vasculature of solid tumors. Breast Cancer Res Treat 36: 237–231, 1995PubMedGoogle Scholar
  2. 2.
    Griffioen AW, Damen C, Martinotti S, Blijham GH, Groenewegen G: Endothelial ICAM-1 expression is suppressed in human malignancies: role of angiogenic factors. Cancer Res, in pressGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1996

Authors and Affiliations

  • Arjan W. Griffioen
    • 1
  • Cora A. Damen
    • 1
  • Geert H. Blijham
    • 1
  • Gerard Groenewegen
    • 1
  1. 1.Dept. of Internal Medicine and Medical Oncology, Laboratory for Angiogenesis Research, F.02.126University Hospital UtrechtUtrechtThe Netherlands

Personalised recommendations